Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89143367 | 8914336 | 7 | F | 2012 | 20160910 | 20121119 | 20160916 | EXP | US-JNJFOC-20121008723 | JANSSEN | 0.00 | A | M | Y | 106.60000 | KG | 20160916 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89143367 | 8914336 | 1 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | Y | U | UNKNOWN | 0 | SOLUTION FOR INJECTION | |||||||
| 89143367 | 8914336 | 2 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | EVERY 2-3 MONTHS | Y | U | UNKNOWN | 0 | 90 | MG | SOLUTION FOR INJECTION | ||||
| 89143367 | 8914336 | 3 | PS | STELARA | USTEKINUMAB | 1 | Subcutaneous | Y | U | UNKNOWN | 125261 | SOLUTION FOR INJECTION | |||||||
| 89143367 | 8914336 | 4 | C | LASIX | FUROSEMIDE | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 89143367 | 8914336 | 5 | C | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | Oral | 0 | 600 | MG | TABLET | /wk | |||||||
| 89143367 | 8914336 | 6 | C | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | Oral | 0 | 600 | MG | TABLET | /wk | |||||||
| 89143367 | 8914336 | 7 | C | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | Oral | 0 | 600 | MG | TABLET | /wk | |||||||
| 89143367 | 8914336 | 8 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | Oral | 0 | 5 | MG | TABLETS | QD | |||||||
| 89143367 | 8914336 | 9 | C | BABY ASPIRIN | ASPIRIN | 1 | Oral | 0 | 81 | MG | TABLETS | QD | |||||||
| 89143367 | 8914336 | 10 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Oral | 0 | 10 | MG | TABLET | QD | |||||||
| 89143367 | 8914336 | 11 | C | ERYTHROMYCIN. | ERYTHROMYCIN | 1 | Unknown | 0 | 600 | MG | UNSPECIFIED | /wk | |||||||
| 89143367 | 8914336 | 12 | C | COUGH SYRUP | DEXTROMETHORPHAN HYDROBROMIDEGUAIFENESIN | 1 | Oral | 1 TEASPOON EVERY 4-6 HOURS | 0 | SOLUTION | |||||||||
| 89143367 | 8914336 | 13 | C | GLYBURIDE. | GLYBURIDE | 1 | Oral | 1.25 | 0 | TABLET | |||||||||
| 89143367 | 8914336 | 14 | C | COZAAR | LOSARTAN POTASSIUM | 1 | Oral | 0 | 50 | MG | TABLET | ||||||||
| 89143367 | 8914336 | 15 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 0 | 20 | MG | TABLET | ||||||||
| 89143367 | 8914336 | 16 | C | MUCINEX | GUAIFENESIN | 1 | Oral | 0 | 600 | MG | TABLET | Q8H | |||||||
| 89143367 | 8914336 | 17 | C | QVAR | BECLOMETHASONE DIPROPIONATE | 1 | Unknown | 2 PUFFS | 0 | .08 | MG | INHALATION | BID | ||||||
| 89143367 | 8914336 | 18 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Unknown | 4/5/M,2 PUFFS | 0 | INHALATION | |||||||||
| 89143367 | 8914336 | 19 | C | COZAAR | LOSARTAN POTASSIUM | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 89143367 | 8914336 | 20 | C | CETRIZINE | CETIRIZINE HYDROCHLORIDE | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 89143367 | 8914336 | 21 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 89143367 | 8914336 | 22 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | Unknown | AS NEEDED | 0 | UNSPECIFIED | |||||||||
| 89143367 | 8914336 | 23 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 89143367 | 8914336 | 1 | Psoriasis |
| 89143367 | 8914336 | 2 | Psoriasis |
| 89143367 | 8914336 | 3 | Psoriasis |
| 89143367 | 8914336 | 5 | Lung infection |
| 89143367 | 8914336 | 6 | Infection prophylaxis |
| 89143367 | 8914336 | 7 | Prophylaxis |
| 89143367 | 8914336 | 8 | Hypertension |
| 89143367 | 8914336 | 10 | Asthma |
| 89143367 | 8914336 | 11 | Infection prophylaxis |
| 89143367 | 8914336 | 12 | Productive cough |
| 89143367 | 8914336 | 13 | Diabetes mellitus |
| 89143367 | 8914336 | 14 | Blood pressure measurement |
| 89143367 | 8914336 | 19 | Blood pressure measurement |
| 89143367 | 8914336 | 20 | Multiple allergies |
| 89143367 | 8914336 | 23 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 89143367 | 8914336 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 89143367 | 8914336 | Adverse event | |
| 89143367 | 8914336 | Anxiety | |
| 89143367 | 8914336 | Arthralgia | |
| 89143367 | 8914336 | Arthritis | |
| 89143367 | 8914336 | Asthenia | |
| 89143367 | 8914336 | Cataract | |
| 89143367 | 8914336 | Confusional state | |
| 89143367 | 8914336 | Cough | |
| 89143367 | 8914336 | Diabetes mellitus | |
| 89143367 | 8914336 | Dry eye | |
| 89143367 | 8914336 | Dry mouth | |
| 89143367 | 8914336 | Eye irritation | |
| 89143367 | 8914336 | Fatigue | |
| 89143367 | 8914336 | Gastrooesophageal reflux disease | |
| 89143367 | 8914336 | Haemorrhoidal haemorrhage | |
| 89143367 | 8914336 | Hyperaesthesia | |
| 89143367 | 8914336 | Ill-defined disorder | |
| 89143367 | 8914336 | Insomnia | |
| 89143367 | 8914336 | Ligament injury | |
| 89143367 | 8914336 | Lung disorder | |
| 89143367 | 8914336 | Lymphadenopathy | |
| 89143367 | 8914336 | Multiple allergies | |
| 89143367 | 8914336 | Muscle tightness | |
| 89143367 | 8914336 | Muscular weakness | |
| 89143367 | 8914336 | Myalgia | |
| 89143367 | 8914336 | Mycobacterium avium complex infection | |
| 89143367 | 8914336 | Oedema peripheral | |
| 89143367 | 8914336 | Pain | |
| 89143367 | 8914336 | Pemphigus | |
| 89143367 | 8914336 | Skin burning sensation | |
| 89143367 | 8914336 | Sleep apnoea syndrome | |
| 89143367 | 8914336 | Sluggishness | |
| 89143367 | 8914336 | Sputum increased | |
| 89143367 | 8914336 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 89143367 | 8914336 | 1 | 2011 | 2012 | 0 | |
| 89143367 | 8914336 | 2 | 2013 | 0 | ||
| 89143367 | 8914336 | 3 | 2012 | 0 | ||
| 89143367 | 8914336 | 4 | 2016 | 0 | ||
| 89143367 | 8914336 | 5 | 2012 | 0 | ||
| 89143367 | 8914336 | 6 | 2012 | 0 | ||
| 89143367 | 8914336 | 7 | 2012 | 0 | ||
| 89143367 | 8914336 | 8 | 2011 | 0 | ||
| 89143367 | 8914336 | 9 | 2011 | 0 | ||
| 89143367 | 8914336 | 14 | 2015 | 0 | ||
| 89143367 | 8914336 | 20 | 2016 | 0 | ||
| 89143367 | 8914336 | 21 | 2011 | 0 | ||
| 89143367 | 8914336 | 22 | 2011 | 0 |